Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of metabolic disorders. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://delilahetlf498213.laowaiblog.com/37749712/retaglutide-a-promising-glp-1-receptor-agonist